2006 - is a professionally managed company espoused to the cause of taming and tailoring information technology to suit the singular needs of the client organizations. - the products are designed and built by the company such as Communication systems, Control Systems, Consumer Eleletronics, Design Services. - the company provides services such as ERP solutions,Web solutions, Staff Augmentation and BPO services 2011 -The Company has changed its name from Jeevan Softech Ltd to Jeevan Scientific Technology Ltd. 2014 -Jeevan has acquired new facility in Near Lanco Hills, Hyderabad. -Mr. Rajendra Prasad has been appointed as a whole time Director of the company. 2015 -"Bioanalytical Facility" from Directorate General of Health Services Office of Drug Controller General (India) (Drugs Control Section). -Workshop on Pharmacokinetics and Biostatistics -Jeevan has attended the 8th International Annual Conference on ÂTranslational Clinical Pharmacology Research in Drug Development in Mumbai -Jeevan Scientific New IT Division -Jeevan Scientific is now registered with USFDA as ÂSelf-identifiedÂ; site following GDUFA 2012 act. -ENHOPS Solutions Pvt Ltd, a wholly owned subsidiary company of Jeevan Scientific Technology Ltd. has been formed. -Jeevan Scientific has participated in CPHI worldwide conference at Spain -Jeevan Scientific has participated in CPHI conference at India 2016 - Jeevan Scientific Technology Ltd Amendment to the Memorandum of Association of the Company. - The Company's Clinical Pharmacology Centre to conduct Bioavailability/Bioequivalence studies has been approved by the Office of Drug Control General, India (DCGI) 2017 -Successfully completed our First USFDA inspection to Bioanalytical facility. Concluded with no 483. 2019 -Reached mark of 200 studies in a span of 2 years from the date of initiation of our first full scope BE study in Feb 2017 2020 -Jeevan Scientific has established an exceptional and complex service portfolio of GLUCOSE CLAMPING TECHNIQUE PHASE I UNIT |
Disclaimer: This is 3rd Party content/feed, viewers are requested to use their discretion and conduct proper diligence before investing, GoodReturns does not take any liability on the genuineness and correctness of the information in this article